• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溴代棒曲霉素环氧化物和溴代棒曲霉素F对小牛肝脏胞质β-葡萄糖苷酶的活性位点定向抑制作用。

Active site directed inhibition of a cytosolic beta-glucosidase from calf liver by bromoconduritol B epoxide and bromoconduritol F.

作者信息

Legler G, Bieberich E

机构信息

Institut für Biochemie, Universität Köln, Federal Republic of Germany.

出版信息

Arch Biochem Biophys. 1988 Jan;260(1):437-42. doi: 10.1016/0003-9861(88)90467-5.

DOI:10.1016/0003-9861(88)90467-5
PMID:3124752
Abstract

Hydrolysis of p-nitrophenyl-beta-D-glucoside by cytosolic beta-glucosidase proceeds with retention of the anomeric configuration. Whereas inactivation of the enzyme by the glucosidase inhibitor conduritol B epoxide (CBE) was extremely slow (ki(max)/Ki 0.57 M-1 min-1) it reacted 130 times more rapidly with 6-bromo-6-deoxy-CBE (Br-CBE). The beta-glucosidase could be labeled with [3H]Br-CBE; incorporation of 1 mol inhibitor/mol enzyme resulted in complete loss of activity. Most of the bound inhibitor was released after denaturation and treatment with ammonia as (1,3,4/2,5,6)-6-bromocyclohexanepentol, thus demonstrating the formation of an ester bond with an active site carboxylate by trans-diaxial opening of the epoxide ring. It was concluded from the Ki values for the epoxide inhibitors and for coduritol B with the cytosolic enzyme and corresponding data for the lysosomal beta-glucosidase that the unusually low reactivity with CBE and Br-CBE is probably due to the inability of the cytosolic enzyme to effectively donate a proton to the epoxide oxygen. An extremely rapid inactivation of the cytosolic beta-glucosidase was caused by bromoconduritol F ((1,2,4/3)-1-bromo-2,3,4-trihydroxycyclohex-5-ene) with ki(max)/Ki 10(5) M-1 min-1. In contrast with the Br-CBE-inhibited enzyme the beta-glucosidase inhibited by bromoconduritol F was subject to spontaneous reactivation with t1/2 approximately 20 min.

摘要

胞质β-葡萄糖苷酶催化对硝基苯基-β-D-葡萄糖苷水解时,端基异构构型得以保留。虽然葡萄糖苷酶抑制剂conduritol B环氧化物(CBE)使该酶失活的速度极慢(ki(max)/Ki为0.57 M-1 min-1),但它与6-溴-6-脱氧-CBE(Br-CBE)的反应速度要快130倍。β-葡萄糖苷酶可用[3H]Br-CBE进行标记;每摩尔酶掺入1摩尔抑制剂会导致活性完全丧失。大多数结合的抑制剂在变性并用氨处理后以(1,3,4/2,5,6)-6-溴环己五醇的形式释放出来,从而证明通过环氧化物环的反式双轴开环与活性位点羧酸盐形成了酯键。从环氧化物抑制剂和coduritol B对胞质酶的Ki值以及溶酶体β-葡萄糖苷酶的相应数据可以得出结论,与CBE和Br-CBE反应异常缓慢可能是由于胞质酶无法有效地向环氧化物氧提供质子。溴代conduritol F((1,2,4/3)-1-溴-2,3,4-三羟基环己-5-烯)能使胞质β-葡萄糖苷酶极快速失活,ki(max)/Ki为10(5) M-1 min-1。与Br-CBE抑制的酶不同,溴代conduritol F抑制的β-葡萄糖苷酶会自发重新激活,半衰期约为20分钟。

相似文献

1
Active site directed inhibition of a cytosolic beta-glucosidase from calf liver by bromoconduritol B epoxide and bromoconduritol F.溴代棒曲霉素环氧化物和溴代棒曲霉素F对小牛肝脏胞质β-葡萄糖苷酶的活性位点定向抑制作用。
Arch Biochem Biophys. 1988 Jan;260(1):437-42. doi: 10.1016/0003-9861(88)90467-5.
2
Inhibition of formation of complex oligosaccharides by the glucosidase inhibitor bromoconduritol.葡萄糖苷酶抑制剂溴代松柏醇对复合寡糖形成的抑制作用。
Proc Natl Acad Sci U S A. 1982 Nov;79(22):6787-91. doi: 10.1073/pnas.79.22.6787.
3
Human acid beta-glucosidase. Use of conduritol B epoxide derivatives to investigate the catalytically active normal and Gaucher disease enzymes.人酸性β-葡萄糖苷酶。使用千金藤醇B环氧化物衍生物研究具有催化活性的正常和戈谢病酶。
J Biol Chem. 1986 Jun 25;261(18):8263-9.
4
Expression of cytosolic beta-glucosidase in guinea pig liver cells.
Hepatology. 1998 Jul;28(1):156-63. doi: 10.1002/hep.510280121.
5
Effect of bromoconduritol on glucosidase II from rat liver. A new kinetic model for the binding and hydrolysis of the substrate.溴脱氧半乳糖醇对大鼠肝脏葡萄糖苷酶II的影响。底物结合与水解的新动力学模型。
Eur J Biochem. 1993 Jul 1;215(1):37-42. doi: 10.1111/j.1432-1033.1993.tb18004.x.
6
Inactivation of alpha-glucosidase by the active-site-directed inhibitor, conduritol B epoxide.活性位点导向抑制剂conduritol B环氧化物对α-葡萄糖苷酶的失活作用。
Biochim Biophys Acta. 1985 Apr 29;828(3):236-40.
7
Kinetic analysis of the interaction of alkyl glycosides with two human beta-glucosidases.烷基糖苷与两种人β-葡萄糖苷酶相互作用的动力学分析
Biochem J. 1989 Sep 1;262(2):541-8. doi: 10.1042/bj2620541.
8
Isolation of a cytosolic beta-glucosidase from calf liver and characterization of its active site with alkyl glucosides and basic glycosyl derivatives.
Arch Biochem Biophys. 1988 Jan;260(1):427-36. doi: 10.1016/0003-9861(88)90466-3.
9
beta-Glucosidase inhibition in murine peritoneal macrophages by conduritol-B-epoxide: an in vitro model of the Gaucher cell.伴刀豆球蛋白B-环氧化物对小鼠腹腔巨噬细胞中β-葡萄糖苷酶的抑制作用:戈谢细胞的体外模型
Biochim Biophys Acta. 1986 Jun 11;877(1):121-6. doi: 10.1016/0005-2760(86)90126-8.
10
In vivo inactivation of glycosidases by conduritol B epoxide and cyclophellitol as revealed by activity-based protein profiling.基于活性的蛋白质谱分析揭示了环氧甘露糖醇和环磷醇通过体内失活糖苷酶。
FEBS J. 2019 Feb;286(3):584-600. doi: 10.1111/febs.14744. Epub 2019 Feb 2.

引用本文的文献

1
Identification of a feedback loop involving β-glucosidase 2 and its product sphingosine sheds light on the molecular mechanisms in Gaucher disease.鉴定涉及β-葡萄糖苷酶2及其产物鞘氨醇的反馈回路,为戈谢病的分子机制提供了线索。
J Biol Chem. 2017 Apr 14;292(15):6177-6189. doi: 10.1074/jbc.M116.762831. Epub 2017 Mar 3.
2
Substrate (aglycone) specificity of human cytosolic beta-glucosidase.人胞质β-葡萄糖苷酶的底物(苷元)特异性
Biochem J. 2003 Jul 1;373(Pt 1):41-8. doi: 10.1042/BJ20021876.
3
Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function.
最佳的哺乳动物皮肤渗透屏障功能需要表皮葡糖神经酰胺的加工过程。
J Clin Invest. 1993 Apr;91(4):1656-64. doi: 10.1172/JCI116374.
4
Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease.表皮中β-葡萄糖脑苷脂酶缺乏的后果。戈谢病中的超微结构和通透性屏障改变。
J Clin Invest. 1994 Apr;93(4):1756-64. doi: 10.1172/JCI117160.
5
In vivo inhibition of beta-glucosidase and beta-mannosidase activity in rats by 2-deoxy-2-fluoro-beta-glycosyl fluorides and recovery of activity in vivo and in vitro.2-脱氧-2-氟-β-糖基氟化物对大鼠体内β-葡萄糖苷酶和β-甘露糖苷酶活性的抑制作用以及体内和体外活性的恢复
Biochem J. 1994 Jul 15;301 ( Pt 2)(Pt 2):343-8. doi: 10.1042/bj3010343.